Clinical trial
Urinary Excretion of Acetylamantadine by Cancer Patients
NCT02277938 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urinary Excretion of Acetylamantadine by Cancer Patients
- Lead sponsor
- University of Manitoba
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2013
- Completion date
- December 31, 2021
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer